- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0007529

Santrash Private Limited
About Santrash Private Limited
Data last updated:
Santrash Private Limited is a private limited company based in Delhi, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 24 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2020PTC368556.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shailendra Kumar Chaurasia and Shailesh Chaurasiya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at K – 1 /12 Top Floor Reliance Fresh Mohan Garden Uttam Nagar Delhi 110059, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.97 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4,586 (net margin 0.4%) and EBITDA of ₹22,302 (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 69% over three years.
The company is associated with 1 brand: Prasad Seed.
Santrash Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0007529).
Company details
Recognitions & Rankings of Santrash
Contact details
Santrash Private Limited's registered office is in Delhi, Delhi.
- Registered AddressK – 1 /12 Top Floor Reliance Fresh Mohan Garden Uttam Nagar Delhi 110059, Delhi, India – 110059
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Santrash operates one associated brand: Prasad Seed. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Sustainable company providing vegetable and fruit seeds to Indian farmers. | prasadseed.com |
Business activity
The main business activity of Santrash is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Santrash Private Limited, buy the company report.
Financials of Santrash Private Limited
FY 2024 filings availableSantrash Private Limited reported revenue of ₹10.97 Lakh (up 694% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 69% over three years, including 694% growth in the latest year. EBITDA rose 179% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹22,302 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹4,586 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2% | |||
| Net Profit Margin | 0.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Santrash Private Limited, buy the company report.
Board of directors of Santrash Private Limited
Santrash has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailendra Kumar Chaurasia Also directs: Enjoy Offer Private Limited | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Shailesh Chaurasiya | Additional Director | 22 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Santrash Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Velocity Healthcare India Private Limited | ₹11.45 Lakh (FY 2025) | -42.0% | New Delhi, Delhi, India | |||
| Jaiwanti Pharmacare Private Limited | ₹11.42 Lakh (FY 2025) | Paonta Sahib, Himachal Pradesh, India | ||||
| Ranga Pharmaceuticals Private Limited | ₹11.28 Lakh (FY 2024) | 644.0% | Ramanagara, Karnataka, India | |||
| RJMS Agro Private Limited | ₹11.22 Lakh (FY 2024) | Vasai, Maharashtra, India | ||||
| Atoffy Lifesciences Private Limited | ₹11.04 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Santrash Private Limitedthis company | ₹10.97 Lakh (FY 2024) | ₹4,586 | 0.4% | 694.0% | Delhi, India | |
| Pooja Agro Chemicals and Fertilizers Private Limited | ₹10.89 Lakh (FY 2025) | -3.0% | Nashik, Maharashtra, India | |||
| Pintu's PP Products Private Limited | ₹10.89 Lakh (FY 2025) | Thane, Maharashtra, India | ||||
| Pleiadian Pharma Private Limited | ₹10.85 Lakh (FY 2025) | -22.0% | Delhi, India | |||
| Scoots Pharmaceutical Private Limited | ₹10.77 Lakh (FY 2025) | 161.0% | Delhi, India | |||
| Maxlead Sciences Private Limited | ₹10.58 Lakh (FY 2024) | Surat, Gujarat, India |
To see the full peer comparison of Santrash Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Santrash Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Santrash Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Santrash Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Santrash Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Shailesh Chaurasiya was appointed as Additional Director on 22 Aug 2025.
Frequently asked questions
Santrash is an active private limited company based in Delhi, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 24 August 2020 (6+ years old) and is registered under CIN U33100DL2020PTC368556.
Santrash has 2 current directors:
- Shailendra Kumar Chaurasia - Director
- Shailesh Chaurasiya - Additional Director
The latest financial statements of Santrash on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Santrash is U33100DL2020PTC368556. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Santrash was incorporated on 24 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Santrash by revenue are Velocity Healthcare India Private Limited, Jaiwanti Pharmacare Private Limited, Ranga Pharmaceuticals Private Limited, RJMS Agro Private Limited, Atoffy Lifesciences Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Shailesh Chaurasiya was appointed as Additional Director on 22 Aug 2025. Santosh Kumar Jaiswal was appointed as Director on 24 Aug 2020. Shailendra Kumar Chaurasia was appointed as Director on 24 Aug 2020.
Yes, Santrash is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0007529).
The registered office of Santrash is at K – 1 12 Top Floor Reliance Fresh Mohan Garden Uttam Nagar Delhi 110059, Delhi, India – 110059.
Santrash operates in the healthcare industry, in the medical appliances and instruments segment.
Santrash has 1 associated brand: Prasad Seed.

